VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 166 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,239 | -61.3% | 239 | +1.3% | 0.00% | – |
| Q2 2023 | $5,789 | +8.2% | 236 | +2.6% | 0.00% | – |
| Q1 2023 | $5,352 | -8.1% | 230 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $5,821 | -75.7% | 230 | -81.3% | 0.00% | -50.0% |
| Q3 2022 | $24,000 | -22.6% | 1,230 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $31,000 | -3.1% | 1,230 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $32,000 | -38.5% | 1,230 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $52,000 | -64.4% | 1,230 | -63.3% | 0.00% | -70.0% |
| Q3 2021 | $146,000 | +43.1% | 3,350 | +55.8% | 0.01% | +42.9% |
| Q2 2021 | $102,000 | – | 2,150 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |